Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes

Jonathan D. Taylor(AstraZeneca (Singapore)), Sandrine Legg(AstraZeneca (United Kingdom))
Communications Biology
September 19, 2024
Cited by 15


Related Papers

No related papers found

Powered by citation graph analysis